TY - JOUR
T1 - Association between common cardiovascular risk factors and clinical phenotype in patients with hypertrophic cardiomyopathy from the European Society of Cardiology (ESC) EurObservational Research Programme (EORP) Cardiomyopathy/Myocarditis registry
AU - Lopes, Luis R.
AU - Losi, Maria Angela
AU - Sheikh, Nabeel
AU - Laroche, Cécile
AU - Charron, Philippe
AU - Gimeno, Juan
AU - Kaski, Juan P.
AU - Maggioni, Aldo P.
AU - Tavazzi, Luigi
AU - Arbustini, Eloisa
AU - Brito, Duke
AU - Celutkiene, Jelena
AU - Hagege, Albert
AU - Linhart, Ales
AU - Mogensen, Jens
AU - Garcia-Pinilla, José Manuel
AU - Ripoll-Vera, Tomas
AU - Seggewiss, Hubert
AU - Villacorta, Eduardo
AU - Caforio, Alida
AU - Elliott, Perry M.
AU - Gale, Christopher Peter
AU - Beleslin, Branko
AU - Bu-Daj, Andrzej
AU - Chioncel, Ovidiu
AU - Dagres, Nikolaos
AU - Danchin, Nicolas
AU - Erlinge, David
AU - Emberson, Jonathan
AU - Glikson, Michael
AU - Gray, Alastair
AU - Kayikcioglu, Meral
AU - Nagy, Klaudia Vivien
AU - Nedoshivin, Aleksandr
AU - Petronio, Anna Sonia
AU - Hesselink, Jolien Roo
AU - Wallentin, Lars
AU - Zeymer, Uwe
AU - Blanes, Juan Ramon Gimeno
AU - Tendera, Michal
AU - Hey, T.
AU - Ali, M.
AU - Felix, S. B.
AU - Smith, M.
AU - Sammani, A.
AU - Van Der Heijden, J.
AU - Van Laake, L.
AU - De Jonge, N.
AU - Hassink, R.
AU - Kirkels, J. H.
N1 - Publisher Copyright:
© The Author(s) 2022.
PY - 2023/1/1
Y1 - 2023/1/1
N2 - Aims The interaction between common cardiovascular risk factors (CVRF) and hypertrophic cardiomyopathy (HCM) is poorly studied. We sought to explore the relation between CVRF and the clinical characteristics of patients with HCM enrolled in the EURObservational Research Programme (EORP) Cardiomyopathy registry Methods and results: 1739 patients with HCM were studied. The relation between hypertension (HT), diabetes (DM), body mass index (BMI), and clinical traits was analysed. Analyses were stratified according to the presence or absence of a pathogenic variant in a sarcomere gene. The prevalence of HT, DM, and obesity (Ob) was 37, 10, and 21%, respectively. HT, DM, and Ob were associated with older age (P<0.001), less family history of HCM (HT and DM P<0.001), higher New York Heart Association (NYHA) class (P<0.001), atrial fibrillation (HT and DM P<0.001; Ob p = 0.03) and LV (left ventricular) diastolic dysfunction (HT and Ob P<0.001; DM P = 0.003). Stroke was more frequent in HT (P<0.001) and mutation-positive patients with DM (P = 0.02). HT and Ob were associated with higher provocable LV outflow tract gradients (HT P<0.001, Ob P = 0.036). LV hypertrophy was more severe in Ob (P = 0.018). HT and Ob were independently associated with NYHA class (OR 1.419, P = 0.017 and OR 1.584, P = 0.004, respectively). Other associations, including a higher proportion of females in HT and of systolic dysfunction in HT and Ob, were observed only in mutation-positive patients. Conclusion Common CVRF are associated with a more severe HCM phenotype, suggesting a proactive management of CVRF should be promoted. An interaction between genotype and CVRF was observed for some traits.
AB - Aims The interaction between common cardiovascular risk factors (CVRF) and hypertrophic cardiomyopathy (HCM) is poorly studied. We sought to explore the relation between CVRF and the clinical characteristics of patients with HCM enrolled in the EURObservational Research Programme (EORP) Cardiomyopathy registry Methods and results: 1739 patients with HCM were studied. The relation between hypertension (HT), diabetes (DM), body mass index (BMI), and clinical traits was analysed. Analyses were stratified according to the presence or absence of a pathogenic variant in a sarcomere gene. The prevalence of HT, DM, and obesity (Ob) was 37, 10, and 21%, respectively. HT, DM, and Ob were associated with older age (P<0.001), less family history of HCM (HT and DM P<0.001), higher New York Heart Association (NYHA) class (P<0.001), atrial fibrillation (HT and DM P<0.001; Ob p = 0.03) and LV (left ventricular) diastolic dysfunction (HT and Ob P<0.001; DM P = 0.003). Stroke was more frequent in HT (P<0.001) and mutation-positive patients with DM (P = 0.02). HT and Ob were associated with higher provocable LV outflow tract gradients (HT P<0.001, Ob P = 0.036). LV hypertrophy was more severe in Ob (P = 0.018). HT and Ob were independently associated with NYHA class (OR 1.419, P = 0.017 and OR 1.584, P = 0.004, respectively). Other associations, including a higher proportion of females in HT and of systolic dysfunction in HT and Ob, were observed only in mutation-positive patients. Conclusion Common CVRF are associated with a more severe HCM phenotype, suggesting a proactive management of CVRF should be promoted. An interaction between genotype and CVRF was observed for some traits.
KW - Cardiovascular risk factors
KW - Diabetes
KW - Genotype
KW - Hypertension
KW - Hypertrophic cardiomyopathy
KW - Obesity
UR - http://www.scopus.com/inward/record.url?scp=85136423278&partnerID=8YFLogxK
U2 - 10.1093/ehjqcco/qcac006
DO - 10.1093/ehjqcco/qcac006
M3 - Article
C2 - 35138368
AN - SCOPUS:85136423278
SN - 2058-5225
VL - 9
SP - 42
EP - 53
JO - European Heart Journal - Quality of Care and Clinical Outcomes
JF - European Heart Journal - Quality of Care and Clinical Outcomes
IS - 1
ER -